CBZ vs. SLNO
CBZ (CBIZ, Inc.) and SLNO (Soleno Therapeutics, Inc.) are both stocks. CBZ operates in Specialty Business Services (Industrials), while SLNO operates in Biotechnology (Healthcare). Over the past 10 years, CBZ returned 12.20%/yr vs -5.77%/yr for SLNO. At a 0.08 correlation, their price movements are largely independent.
Performance
CBZ vs. SLNO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CBZ achieves a -33.08% return, which is significantly lower than SLNO's 14.49% return. Over the past 10 years, CBZ has outperformed SLNO with an annualized return of 12.20%, while SLNO has yielded a comparatively lower -5.77% annualized return.
CBZ
- 1D
- -2.65%
- 1M
- 4.98%
- YTD
- -33.08%
- 6M
- -32.15%
- 1Y
- -52.84%
- 3Y*
- -13.87%
- 5Y*
- 0.55%
- 10Y*
- 12.20%
SLNO
- 1D
- 0.00%
- 1M
- 0.26%
- YTD
- 14.49%
- 6M
- 10.17%
- 1Y
- -29.94%
- 3Y*
- 122.08%
- 5Y*
- 28.47%
- 10Y*
- -5.77%
CBZ vs. SLNO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CBZ CBIZ, Inc. | -33.08% | -38.35% | 30.74% | 33.60% | 19.76% | 47.01% | -1.30% | 36.85% | 27.51% | 12.77% |
SLNO Soleno Therapeutics, Inc. | 14.49% | 3.00% | 11.68% | 1,932.83% | -67.80% | -78.76% | -34.35% | 71.93% | -5.00% | -55.56% |
Correlation
The correlation between CBZ and SLNO is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.03 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Nov 14, 2014 | 0.08 |
Fundamentals
CBZ:
$2.08B
SLNO:
$2.81B
CBZ:
$2.45
SLNO:
$1.81
CBZ:
13.79
SLNO:
29.36
CBZ:
0.77
SLNO:
9.90
CBZ:
1.10
SLNO:
5.67
CBZ:
$2.77B
SLNO:
$285.01M
CBZ:
$353.31M
SLNO:
$187.70M
CBZ:
$445.96M
SLNO:
$101.57M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CBZ vs. SLNO — Risk / Return Rank
CBZ
SLNO
CBZ vs. SLNO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CBIZ, Inc. (CBZ) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CBZ | SLNO | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -1.02 | -0.43 | -0.59 |
Sortino ratioReturn per unit of downside risk | -1.50 | -0.26 | -1.25 |
Omega ratioGain probability vs. loss probability | 0.80 | 0.96 | -0.16 |
Calmar ratioReturn relative to maximum drawdown | -0.79 | -0.44 | -0.34 |
Martin ratioReturn relative to average drawdown | -1.27 | -0.76 | -0.51 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CBZ | SLNO | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.02 | -0.43 | -0.59 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | 0.12 | -0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | -0.03 | +0.43 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.17 | -0.07 | +0.25 |
Drawdowns
CBZ vs. SLNO - Drawdown Comparison
The maximum CBZ drawdown since its inception was -96.13%, roughly equal to the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for CBZ and SLNO.
Loading charts...
Drawdown Indicators
| CBZ | SLNO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.13% | -99.86% | +3.73% |
Max Drawdown (1Y)Largest decline over 1 year | -67.69% | -66.04% | -1.65% |
Max Drawdown (3Y)Largest decline over 3 years | -71.64% | -66.04% | -5.60% |
Max Drawdown (5Y)Largest decline over 5 years | -71.64% | -94.96% | +23.32% |
Max Drawdown (10Y)Largest decline over 10 years | -71.64% | -99.06% | +27.42% |
Current DrawdownCurrent decline from peak | -61.92% | -91.92% | +30.00% |
Average DrawdownAverage peak-to-trough decline | -51.04% | -90.59% | +39.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.00% | 38.58% | +3.42% |
Volatility
CBZ vs. SLNO - Volatility Comparison
CBIZ, Inc. (CBZ) has a higher volatility of 14.63% compared to Soleno Therapeutics, Inc. (SLNO) at 0.32%. This indicates that CBZ's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CBZ | SLNO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.63% | 0.32% | +14.31% |
Volatility (6M)Calculated over the trailing 6-month period | 43.22% | 44.82% | -1.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.99% | 69.01% | -17.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.09% | 243.64% | -209.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 30.84% | 185.28% | -154.44% |
Dividends
CBZ vs. SLNO - Dividend Comparison
Neither CBZ nor SLNO has paid dividends to shareholders.
Financials
CBZ vs. SLNO - Financials Comparison
This section allows you to compare key financial metrics between CBIZ, Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CBZ vs. SLNO - Profitability Comparison
CBZ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CBIZ, Inc. reported a gross profit of 226.02M and revenue of 848.58M. Therefore, the gross margin over that period was 26.6%.
SLNO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported a gross profit of 0.00 and revenue of 94.60M. Therefore, the gross margin over that period was 0.0%.
CBZ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CBIZ, Inc. reported an operating income of 196.45M and revenue of 848.58M, resulting in an operating margin of 23.2%.
SLNO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported an operating income of 31.28M and revenue of 94.60M, resulting in an operating margin of 33.1%.
CBZ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CBIZ, Inc. reported a net income of 161.61M and revenue of 848.58M, resulting in a net margin of 19.1%.
SLNO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Soleno Therapeutics, Inc. reported a net income of 31.38M and revenue of 94.60M, resulting in a net margin of 33.2%.
Frequently Asked Questions
CBZ and SLNO have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CBZ has higher volatility (14.63%) compared to SLNO (0.32%). In terms of maximum drawdown, CBZ dropped -96.13% vs SLNO's -99.86%.
SLNO currently has the higher Sharpe Ratio (-0.43 vs -1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CBZ and SLNO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer